Sector revisions Perrigo Company plc

Equities

Market Closed - Nyse Other stock markets 04:00:02 2026-02-10 pm EST			5-day change	1st Jan Change
14.39 ^USD	+0.49%		+1.77%	+3.38%

Jan. 12	Ansell Limited Announces Appointment of Ansell Limited as Independent Non-Executive Director , with Effect on March 1, 2026	CI
Dec. 21	Perrigo Company plc(NYSE:PRGO) added to S&P 600 Health Care	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	PERRIGO COMPANY PLC							4
	ELI LILLY AND COMPANY							27
	JOHNSON & JOHNSON							24
	ABBVIE INC.							27
	ROCHE HOLDING AG							20
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	MERCK & CO., INC.							26
	NOVO NORDISK A/S							22
	AMGEN INC.							27
	GILEAD SCIENCES, INC.							25
	PFIZER INC.							23
	BRISTOL-MYERS SQUIBB COMPANY							23
	VERTEX PHARMACEUTICALS INCORPORATED							25
	GSK PLC							20
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	Average							21
	Weighted average by Cap.							24